Diferencia entre revisiones de «Pediatric fever of uncertain source»

(/* Evolving Practices for Febrile Infants 0-60 days (2019 JAMA Peds)Kuppermann N, Dayan PS, Levine DA, et al. A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections. JAMA Pediatrics. 2019...)
 
(No se muestran 26 ediciones intermedias de 3 usuarios)
Línea 1: Línea 1:
==Background==
==Background==
*Medicine is an art as well as science, practice clinical judgment when using guidelines
*Preemies: Count age by estimated postconception date (not by actual delivery date) for 1st-90d
*Fever accounts for 30% of pediatric visits
*Fever accounts for 30% of pediatric visits
*Children <3 mo are immunocompromised- poor opsonization, poor IgG response to encapsulated bacteria, macrophage and neutrophil dysfunction, bone marrow insufficiency
*Children <3 months are immunocompromised (e.g. poor opsonization, poor IgG response to encapsulated bacteria, macrophage and neutrophil dysfunction, bone marrow insufficiency)
*Serious bacterial illness (SBI) includes UTI, meningitis, pneumonia, bacteremia
*Concern is for missing a serious bacterial infection (SBI)


===Epidemiology and Risk===
{| class="wikitable"  
{| class="wikitable"  
| align="center" style="background:#f0f0f0;"|'''Age'''
| align="center" style="background:#f0f0f0;"|'''Age'''
Línea 15: Línea 14:
| align="center" style="background:#f0f0f0;"|'''> 90 days'''
| align="center" style="background:#f0f0f0;"|'''> 90 days'''
|-
|-
| Meningitis/SBI Prevalence ||1/10||1/20||1/100||1/1000||1/1000-10,000||> 1/10,000
| [[Meningitis]]/SBI Prevalence ||1/10||1/20||1/100||1/1000||1/1000-10,000||> 1/10,000
|}
|}
*Serious bacterial illness (SBI) includes UTI, meningitis, pneumonia, bacteremia
*7% of patients <2 years old with fever have [[pneumonia]], however the etiology (viral/bacterial) or even the presence of pneumonia has low inter-observer reliability even among pediatric radiologists<ref>ACEP's Clinical Policy on Pediatric Fever. Clinical Policy for Children Younger Than Three Years Presenting to the Emergency Department With Fever. Annuals of Emergency Medicine 2003 42. 530-545</ref>
*4% Prevalence of [[UTI]] with common other sources of fever ([[OM]], viral [[URI]], etc)<ref>ACEP's Clinical Policy on Pediatric Fever. Clinical Policy for Children Younger Than Three Years Presenting to the Emergency Department With Fever. Annuals of Emergency Medicine 2003 42. 530-545</ref>
*0.3% of previously well children aged 3-36 months who have a fever without a source will develop significant sequelae, 0.03% will develop sepsis or meningitis<ref>ACEP's Clinical Policy on Pediatric Fever. Clinical Policy for Children Younger Than Three Years Presenting to the Emergency Department With Fever. Annuals of Emergency Medicine 2003 42. 530-545</ref>


===Facts and Figures===
===Concomitant Respiratory Viral Infection===
*Take parental report of confirmed fever at home seriously in the 0-28 day range, even if never febrile in ED, as this population has been shown to have rates of serious bacterial infection (SBI) as high as 4.7% and invasive bacterial infection (IBI) as high as 1.8%<ref>Serious bacterial infections in neonates presenting afebrile with history of fever Ramgopal S, Walker LW, Tavarez MM, et al. Pediatrics. 2019;144(2):e20183964.</ref>
*Relatively high coincidence of [[RSV]], [[enterovirus]], and [[paraflu]] with bacteremia (and UTIs), so positive lab test for these viruses should not change testing and management plan<ref>Greenes, D.S.M., & Harper, M. B.M. (1999). Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatric Infectious Disease Journal, 18(3), 258-261.</ref>
''From  ACEP's Clinical Policy on Pediatric Fevers<ref>Clinical Policy for Children Younger Than Three Years Presenting to the Emergency Department With Fever. Annuals of Emergency Medicine 2003 42. 530-545</ref>
**[[RSV]]+ neonates aged 0-28 days, 3.7% were bactremic (and 6.1% had [[UTI]]s)  
*7% of patients < 2 years old with fever have pneumonia, however the etiology (viral/bacterial) or even the presence of pneumonia has low inter-observer reliability even among pediatric radiologists
**RSV+ infants aged 29-60 days, (5.5% had [[UTI]]s)
*4% Prevalence of UTI with common other sources of fever (OM, viral URI, et cetera)
*There is a low coincidence of [[influenza]] with SBI, so postivie lab test for this virus may change testing and management plan (i.e. lower risk of concurrent bacterial illness)<ref>Greenes, D.S.M., & Harper, M. B.M. (1999). Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatric Infectious Disease Journal, 18(3), 258-261.</ref>
*1.5-2% background prevalence of asymptomatic bacteriuria in healthy afebrile controls
*0.3% Rate of occult bactremia with healthy, well-appearing child who has a fever 2-24 months
*0.3% of previously well children aged 3-36 months who have a fever without a source will develop significant sequelae, 0.03% will develop sepsis or meningitis
 
===Concomitant [[RSV]] or [[Influenza]] Infection===
*Relatively high coincidence of bronchiolitis w/ UTI, and of enterovirus and paraflu w/ UTI and bacteremia
*In RSV+ (by PCR) neonates aged 0-28 days, 6.1% had UTIs and 3.7% were bactremic; there was no difference in rates of SBI between RSV+ and RSV- neonates in a large prospective multicenter study entailing 1,248 children<ref>Greenes, D.S.M., & Harper, M. B.M. (1999). Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatric Infectious Disease Journal, 18(3), 258-261.</ref>
*RSV+ infants aged 29-60 days, the SBI rate was 5.5%, all of which were UTIs
*Influenza+, low risk of bacterial illness


==Clinical Features==
*[[Acute fever|Febrile]]
**Defined as [[Celsius Fahrenheit Temperature Conversion|temperature]] ≥38°C (100.4°F).
**Peripheral temperature is not clinically accurate and central measurements are the preferred means of determining fever.
**Parental report of confirmed fever at home (i.e. via thermometer), even with no fever in ED, has rates of SBIs high as 4.7% (0-28 day range)<ref>Serious bacterial infections in neonates presenting afebrile with history of fever Ramgopal S, Walker LW, Tavarez MM, et al. Pediatrics. 2019;144(2):e20183964.</ref>


==Differential Diagnosis==
==Differential Diagnosis==
Línea 38: Línea 37:


==Evaluation & Management==
==Evaluation & Management==
*Preemies: Count age by estimated postconception date (not by actual delivery date) for 1st-90d
===0-7 Days===
===0-7 Days===
''For all infants (toxic and well-appearing)''
''For all infants (toxic and well-appearing)''
Línea 76: Línea 77:
*For toxic infants, treat for sepsis and admit
*For toxic infants, treat for sepsis and admit
*For well-appearing infants, see below algorithm
*For well-appearing infants, see below algorithm
[[File:Peds fever 8-21 days.png|8-21 day algorithm]]
[[File:Peds fever 8-21 days (2.0).png|8-21 day algorithm]]


===22-28 Days<ref>Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228 </ref>===
===22-28 Days<ref>Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228 </ref>===
*For toxic infants, treat for sepsis and admit
*For toxic infants, treat for sepsis and admit
*For well-appearing infants, see below algorithm
*For well-appearing infants, see below algorithm
[[File:Peds fever 22-28 days.PNG]]
[[File:Peds fever 22-28 days (2.0).PNG]]


===29-60 Days<ref>Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228 </ref>===
===29-60 Days<ref>Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228 </ref>===
*For toxic infants, treat for sepsis and admit
*For toxic infants, treat for sepsis and admit
*For well-appearing infants, see below algorithm
*For well-appearing infants, see below algorithm
[[File:Peds fever 29-60 days.PNG]]
[[File:Peds fever 29-60 (2.0).PNG]]


===60 Days - 36 Months<ref>Jaskiewicz, J.A., McCarthy, C.A., Richardson, A.C., White, K.C., Fisher, D.J., Powell, K. R., et al. (1994). Febrile infants at low risk for serious bacterial infection-an appraisal of the Rochester criteria and implications for management. Pediatrics 94(3), 390-396.</ref>===
===60 Days - 36 Months<ref>Jaskiewicz, J.A., McCarthy, C.A., Richardson, A.C., White, K.C., Fisher, D.J., Powell, K. R., et al. (1994). Febrile infants at low risk for serious bacterial infection-an appraisal of the Rochester criteria and implications for management. Pediatrics 94(3), 390-396.</ref>===
Línea 143: Línea 144:
*WBC 5-15 /mm<sup>3</sup>
*WBC 5-15 /mm<sup>3</sup>
*Absolute Band count <1500 /mm<sup>3</sup>
*Absolute Band count <1500 /mm<sup>3</sup>
*Procalcitonin ≤0.5 ng/mL
*ANC ≤4000/mm<sup>3</sup>
===Urinalysis===
===Urinalysis===
*Clear
*Clear
Línea 148: Línea 151:
*WBC <10/high powered field
*WBC <10/high powered field
===CSF===
===CSF===
*Studies should include WBC, protein, glucose, Gram stain, and culture for bacteria. Consider viral studies (HSV).
====0-28 days====
====0-28 days====
*WBC: 0-22/mm<sup>3</sup>
*WBC: 0-22/mm<sup>3</sup>
Línea 155: Línea 159:
*Protein: 15-25mg/dL
*Protein: 15-25mg/dL


==Symptomatic Management==
==Additional Management==
===Initial Empiric Antibiotics for Well-Appearing Infants<ref>Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228 </ref>===
===Initial Empiric Antibiotics for Well-Appearing Infants===
{| {{table}}
{{Infant fever well antibiotics}}
| align="center" style="background:#f0f0f0;"|'''Suspected Infection Source'''
| align="center" style="background:#f0f0f0;"|'''8-21 Days Old'''
| align="center" style="background:#f0f0f0;"|'''22-28 Days Old'''
| align="center" style="background:#f0f0f0;"|'''29-60 Days Old'''
|-
| [[UTI]]||
*[[Ampicillin]] IV or IM (150 mg/kg per day divided q8) AND either:
**[[Ceftazidime]] IV or IM (150 mg/kg per day divided q8) or
**[[Gentamicin]] IV or IM (4 mg/kg per dose q24)
||
*[[Ceftriaxone]] IV or IM (50 mg/kg per dose q24)
||
*[[Ceftriaxone]] IV or IM (50 mg/kg per dose q24)
*Oral options:
**[[Cephalexin]] 50-100 mg/kg per day QID or
**[[Cefixime]] 8 mg/kg QD
|-
| No source identified
||
*[[Ampicillin]] IV or IM (150 mg/kg per day divided q8) AND either:
**[[Ceftazidime]] IV or IM (150 mg/kg per day divided q8) or
**[[Gentamicin]] IV or IM (4 mg/kg per dose q24)
||
*[[Ceftriaxone]] IV or IM (50 mg/kg per dose q24)
||
*[[Ceftriaxone]] IV or IM (50 mg/kg per dose q24)
|-
| Bacterial [[meningitis]]
||
*[[Ampicillin]] IV or IM (300 mg/kg per day divided q6) AND
*[[Ceftazidime]] IV or IM (150 mg/kg per day divided q8)
||
*[[Ampicillin]] IV or IM (300 mg/kg per day divided q6) AND
*[[Ceftazidime]] IV or IM (150 mg/kg per day divided q8)
||
*Cephalosporin
**[[Ceftriaxone]] IV (100 mg/kg QD) or
**[[Ceftazidime]] IV (150 mg/kg QD)
*AND [[Vancomycin]] IV (60 mg/kg QD)
|}
 
{{Acetaminophen pediatric dosing chart}}
{{Acetaminophen pediatric dosing chart}}


Línea 208: Línea 171:
*[[Meningitis (peds)]]  
*[[Meningitis (peds)]]  
*[[Febrile seizure]]
*[[Febrile seizure]]
*[[PECARN Febrile Infant]]


==External Links==
==External Links==

Revisión actual - 18:43 5 nov 2025

Background

  • Fever accounts for 30% of pediatric visits
  • Children <3 months are immunocompromised (e.g. poor opsonization, poor IgG response to encapsulated bacteria, macrophage and neutrophil dysfunction, bone marrow insufficiency)
  • Concern is for missing a serious bacterial infection (SBI)

Epidemiology and Risk

Age 0-14 days 14-28 days 28-60 days (pre vaccine) 28-60 days (post vaccine) 60-90 days > 90 days
Meningitis/SBI Prevalence 1/10 1/20 1/100 1/1000 1/1000-10,000 > 1/10,000
  • Serious bacterial illness (SBI) includes UTI, meningitis, pneumonia, bacteremia
  • 7% of patients <2 years old with fever have pneumonia, however the etiology (viral/bacterial) or even the presence of pneumonia has low inter-observer reliability even among pediatric radiologists[1]
  • 4% Prevalence of UTI with common other sources of fever (OM, viral URI, etc)[2]
  • 0.3% of previously well children aged 3-36 months who have a fever without a source will develop significant sequelae, 0.03% will develop sepsis or meningitis[3]

Concomitant Respiratory Viral Infection

  • Relatively high coincidence of RSV, enterovirus, and paraflu with bacteremia (and UTIs), so positive lab test for these viruses should not change testing and management plan[4]
    • RSV+ neonates aged 0-28 days, 3.7% were bactremic (and 6.1% had UTIs)
    • RSV+ infants aged 29-60 days, (5.5% had UTIs)
  • There is a low coincidence of influenza with SBI, so postivie lab test for this virus may change testing and management plan (i.e. lower risk of concurrent bacterial illness)[5]

Clinical Features

  • Febrile
    • Defined as temperature ≥38°C (100.4°F).
    • Peripheral temperature is not clinically accurate and central measurements are the preferred means of determining fever.
    • Parental report of confirmed fever at home (i.e. via thermometer), even with no fever in ED, has rates of SBIs high as 4.7% (0-28 day range)[6]

Differential Diagnosis

Pediatric fever

Evaluation & Management

  • Preemies: Count age by estimated postconception date (not by actual delivery date) for 1st-90d

0-7 Days

For all infants (toxic and well-appearing)

Child Appearance Work Up Treatment Disposition & Follow-up Comments
Temperature ≥38°

Toxic or Well

  • CBC
  • Blood cultures
  • Urinalysis, Urine culture
  • LP-CSF
  • CXR
  • +/- Stool studies (if diarrhea)
 Admit SBI incidence
  • Ill appearing: 13%–21%
  • Not ill appearing: <5%

^Acyclovir if:

  • HSV infection in baby or mother
  • CSF pleocytoisis
  • Concerning skin lesions
  • Seizures
  • Abnormal LFTs

Note:

  • CXR is optional if no resp sx and another source identified
  • LP is necessary even if another source identified due to immature blood-brain barrier
  • Do not give ceftriaxone to children <28d as may cause hyperbilirubinemia

8-21 Days[7]

  • For toxic infants, treat for sepsis and admit
  • For well-appearing infants, see below algorithm

8-21 day algorithm

22-28 Days[8]

  • For toxic infants, treat for sepsis and admit
  • For well-appearing infants, see below algorithm

Peds fever 22-28 days (2.0).PNG

29-60 Days[9]

  • For toxic infants, treat for sepsis and admit
  • For well-appearing infants, see below algorithm

Peds fever 29-60 (2.0).PNG

60 Days - 36 Months[10]

Appearance Work Up Treatment Disposition & Follow-Up
T≥38° + Toxic Admit
T≥39°C + Well + Non-complete Prevnar

(No Prevnar or <4 weeks post 1st Prevnar dose)

If WBC(+): Outpatient (24 hour follow-up)
T≥39°C + Well + Prevnar

(2 Prevnar or ≥4 weeks post 1st Prevnar dose)

  • Urine workup (UA, urine culture) for:
    • Circumcised males <6 months
    • Uncircumcised males <12 months
    • All females
  • +/- CXR
 Treat cystitis or pneumonia if postitive Outpatient (48hour follow up)
T≥38-38.9°C + Well Consider UA, CXR based on symptoms, etc Treat cystitis or pneumonia if positive Outpatient (48-72 hour follow-up)[11]
  • Consider CXR for:
    • Respiratory symptoms
    • Fever >48 hrs
    • Tachypnea
    • Hypoxia
  • Non-UTI SBI incidence of <.4% in children >6 mo

Low Risk Lab Criteria

If low-risk criteria below not met, then perform the LP (if not done) and admit for inpatient antibiotics[12][13]

CBC

  • WBC 5-15 /mm3
  • Absolute Band count <1500 /mm3
  • Procalcitonin ≤0.5 ng/mL
  • ANC ≤4000/mm3

Urinalysis

  • Clear
  • Neg Nitrate and Leukocyte esterase
  • WBC <10/high powered field

CSF

  • Studies should include WBC, protein, glucose, Gram stain, and culture for bacteria. Consider viral studies (HSV).

0-28 days

  • WBC: 0-22/mm3
  • Protein: <100mg/dL

>29 days

  • WBC 0-7/mm3
  • Protein: 15-25mg/dL

Additional Management

Initial Empiric Antibiotics for Well-Appearing Infants

Neonatal Antibiotics by Source[14]

Suspected Infection Source 8-21 Days Old 22-28 Days Old 29-60 Days Old
UTI
  • Ampicillin IV or IM (150 mg/kg per day divided q8) AND either:
No source identified
  • Ampicillin IV or IM (150 mg/kg per day divided q8) AND either:
Bacterial meningitis
  • Ampicillin IV or IM (300 mg/kg per day divided q6) AND
  • Ceftazidime IV or IM (150 mg/kg per day divided q8)
  • Ampicillin IV or IM (300 mg/kg per day divided q6) AND
  • Ceftazidime IV or IM (150 mg/kg per day divided q8)

Acetaminophen Pediatric Dosing Chart

Weight (kg) Weight (lbs) Age Dosage (mg)
3-4 6-11 0-3 mo 40
5-7 12-17 4-11 mo 80
8-10 18-23 1-2 y 120
11-15 24-35 2-3 y 160
16-21 36-47 4-5 y 240
22-26 48-59 6-8 y 320
27-32 60-71 9-10 y 400
33-43 72-95 11 y 480
Dosage can be given q6 hours

See Also

External Links

References

  1. ↑ ACEP's Clinical Policy on Pediatric Fever. Clinical Policy for Children Younger Than Three Years Presenting to the Emergency Department With Fever. Annuals of Emergency Medicine 2003 42. 530-545
  2. ↑ ACEP's Clinical Policy on Pediatric Fever. Clinical Policy for Children Younger Than Three Years Presenting to the Emergency Department With Fever. Annuals of Emergency Medicine 2003 42. 530-545
  3. ↑ ACEP's Clinical Policy on Pediatric Fever. Clinical Policy for Children Younger Than Three Years Presenting to the Emergency Department With Fever. Annuals of Emergency Medicine 2003 42. 530-545
  4. ↑ Greenes, D.S.M., & Harper, M. B.M. (1999). Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatric Infectious Disease Journal, 18(3), 258-261.
  5. ↑ Greenes, D.S.M., & Harper, M. B.M. (1999). Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatric Infectious Disease Journal, 18(3), 258-261.
  6. ↑ Serious bacterial infections in neonates presenting afebrile with history of fever Ramgopal S, Walker LW, Tavarez MM, et al. Pediatrics. 2019;144(2):e20183964.
  7. ↑ Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228
  8. ↑ Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228
  9. ↑ Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228
  10. ↑ Jaskiewicz, J.A., McCarthy, C.A., Richardson, A.C., White, K.C., Fisher, D.J., Powell, K. R., et al. (1994). Febrile infants at low risk for serious bacterial infection-an appraisal of the Rochester criteria and implications for management. Pediatrics 94(3), 390-396.
  11. ↑ Baker, M.D., Bello, L.M., & Avner, J.R. (1993). Outpatient management without antibiotics of fever in selected infants. New England Jouranl of Medicine, 329(20), 1437-1441.
  12. ↑ Smitherman, H.F. & Macias, C.G. (2014). Evaluation and management of fever in the neonate and young infant (less than three months of age) [Electronic Version]. UpToDate,Teach, S.J., Kaplan, SL, Wiley, JF.
  13. ↑ Dagan, R. Sofer, S., Phillip, M., & Shachak, E. (1988). Ambulatory care of febrile infants younger than 2 months of age classified as being at low risk for having serous bacterial infections. Journal of Pediatrics, 112(3), 355-360.
  14. ↑ Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228
Obtenido de «https://www.wikem.org/w/index.php?title=Pediatric_fever_of_uncertain_source&oldid=378436»